🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

7,418 results for “1” Clear

  1. 1.0% C31G SAVVY vaginal gel

    United Therapeutics Europe Ltd

    HIV Infections

    phase 3 small molecule active

    2 trials

  2. 1.0mg/kg/day PRAX-562

    PRECISION BIOSCIENCES INC

    Developmental and Epileptic Encephalopathy 1

    phase 3 small molecule active

    1 trial

  3. 10-week smoking cessation group therapy combined with NicoDerm CQ

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Cessation

    phase 3 other completed

    1 trial

  4. 11C-SB207145, 11C-DASB

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Parkinson's disease, Prodromal phase of Parkinson's disease

    phase 3 small molecule active

    1 trial

  5. 12-Valent Pneumococcal Conjugate Vaccine

    MAIA Biotechnology

    Pneumococcal Vaccines

    phase 3 mab active

    1 trial

  6. 131I-apamistamab

    Actinium Pharmaceuticals

    Acute Leukemia

    phase 3 small molecule active

    1 trial

  7. 177Lu-TLX250

    Telix Innovations

    ccRCC

    phase 3 other active

    1 trial

  8. 177Lu-TLX591

    Telix Innovations

    Metastatic Castration-resistant Prostate Cancer

    phase 3 small molecule active

    1 trial

  9. 18F fluciclovine

    PRECISION BIOSCIENCES INC

    Brain Metastases

    phase 3 small molecule completed

    2 trials

  10. 18F-AV-1451

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Maladie d' Alzheimer, Alzheimer's pathology

    phase 3 small molecule active

    1 trial

  11. 18F-DPA-714

    Pari Pharma GmbH

    Multiple sclerosis

    phase 3 small molecule active

    1 trial

  12. 18F-LBT-999

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Comatose Traumatic Brain Injury patients

    phase 3 small molecule active

    1 trial

  13. 1:1:1 Blood Transfusion Ratio

    United Therapeutics Europe Ltd

    Trauma

    phase 3 mab completed

    1 trial

  14. 1mg elsunersen

    PRECISION BIOSCIENCES INC

    Epileptic Encephalopathy

    phase 3 small molecule active

    1 trial

  15. 20 mg VEC-162

    Vanda Pharmaceuticals Netherlands B.V.

    Insomnia

    phase 3 small molecule completed

    1 trial

  16. 35 mg oral lyophilisate, 25 mg oral lyophilisate, 50 mg oral lyophilisate, VYDURA 75 mg oral lyophilisate

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Acute Migraine (with or without aura)

    phase 3 small molecule active

    1 trial

  17. 36-71 months old children-experimental EV71 vaccine.

    SINOVAC BIOTECH LTD

    Hand, Foot and Mouth Disease

    phase 3 mab completed

    1 trial

  18. 40 mg/day vormatrogine for 12 weeks

    PRECISION BIOSCIENCES INC

    Focal Epilepsy

    phase 3 small molecule active

    1 trial

  19. 400U /0.5ml EV71 vaccine

    SINOVAC BIOTECH LTD

    Hand, Foot and Mouth Disease

    phase 3 mab completed

    1 trial

  20. 4D-150 IVT (3E10 vg/eye)

    4D Molecular Therapeutics

    Macular Neovascularization Secondary to Age-Related Macular Degeneration

    phase 3 mab active

    1 trial

  21. 4D-150 IVT (3E10 vg/eye)

    4D Molecular Therapeutics

    Neovascular Age-Related Macular Degeneration (nAMD)

    phase 3 mab active

    1 trial

  22. 5% Dextrose injection; Solution for injection/infusion, OPDIVO 10 mg/mL concentrate for solution for infusion., 0.9% Sodium Chloride injection; Solution for injection/infusion

    Bristol-Myers Squibb / Pfizer EEIG

    Hepatocellular Carcinoma

    phase 3 small molecule active

    1 trial

  23. 5-FU medac 50 mg/ml, Injektionslösung, Tecentriq 1 200 mg concentrate for solution for infusion, Docetaxel Accord 20 mg/1 ml concentrate for solution for infusion, Leucovorin 10 mg/ml Lösung zur Injektion/ Infusion, Oxaliplatin medac 5 mg/ml concentrate for solution for infusion

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    locally advanced resectable adenocarcinoma of the oesophagogastric junction or the stomach

    phase 3 small molecule active

    1 trial

  24. 601 1.25mg

    Sunshine Biopharma

    Branch Retinal Vein Occlusion

    phase 3 small molecule completed

    2 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources